Kai Hu

6PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 27, 2026
Low-dose CD7 chimeric antigen receptor T cells for relapsed/refractory T-cell lymphomas: a single-arm, open-label, phase Ia/Ib study.

Fan Yang, Rui Liu, Zhonghua Fu

|Jan 27, 2025
Central nervous system posttransplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation successfully treated with combination therapy of acalabrutinib and immunochemotherapy: A case report and literature review.

Peihao Zheng, Teng Xu, Xiaona Zuo

|Mar 27, 2023
Characteristics and prognosis of rrDLBCL with TP53 mutations and a high-risk subgroup represented by the co-mutations of DDX3X-TP53.

Fan Gao, Kai Hu, Peihao Zheng

|Feb 03, 2023
Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy.

Wei Chen, Hui Shi, Zhuojun Liu

|Dec 22, 2022
Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma.

Fan Yang, Hui Shi, Teng Xu

|Dec 09, 2022
The Autologous Hematopoietic Stem Cells Transplantation Combination-Based Chimeric Antigen Receptor T-Cell Therapy Improves Outcomes of Relapsed/Refractory Central Nervous System B-Cell Lymphoma.

Fei Xue, Peihao Zheng, Rui Liu

Pageof 1

Frequent Collaborators

1 joint publications

Wei Chen

1 joint publications

Hui Shi

1 joint publications

Zhuojun Liu

1 joint publications

Fan Yang